Induction of hepatocellular carcinoma by in vivo gene targeting.
about
Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonatesA universal system to select gene-modified hepatocytes in vivoGene transfer in the liver using recombinant adeno-associated virusrAAV-mediated tumorigenesis: still unresolved after an AAV assaultIdentification of rtl1, a retrotransposon-derived imprinted gene, as a novel driver of hepatocarcinogenesisMicroRNA-543 acts as an oncogene by targeting PAQR3 in hepatocellular carcinoma.Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.MicroRNA-424 is down-regulated in hepatocellular carcinoma and suppresses cell migration and invasion through c-Myb.A genome-wide map of adeno-associated virus-mediated human gene targetingGenome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.Adeno-associated viral vectors for the treatment of hemophilia.The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV.Genotoxicity in Mice Following AAV Gene Delivery: A Safety Concern for Human Gene Therapy?SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosisEvidence that the capacity of nongenotoxic carcinogens to induce oxidative stress is subject to marked variability.Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correctionHigh-throughput sequencing reveals principles of adeno-associated virus serotype 2 integrationRecombinant AAV Integration Is Not Associated With Hepatic Genotoxicity in Nonhuman Primates and PatientsSmall regulatory RNAs controlled by genomic imprinting and their contribution to human disease.Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity.Current and future prospects for hemophilia gene therapy.Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models.Silent IL2RG Gene Editing in Human Pluripotent Stem Cells.Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.Fah Knockout Animals as Models for Therapeutic Liver Repopulation.DNA methylation dynamics of a maternally methylated DMR in the mouse Dlk1-Dio3 domain.AAV Infection: Protection from Cancer.Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.Adeno-associated virus finds its disease.miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.Nuclease-Mediated Gene Therapies for Inherited Metabolic Diseases of the Liver.MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
P2860
Q27318381-23D381A2-EE52-46E1-BD52-3CFA6ED6E705Q28468539-4CE0A120-FEA5-4872-AFF3-0359C10ACC03Q34164885-6154FAB5-1C20-412F-9450-6028CF087B8DQ34310293-1D6B7355-D4B3-4A0A-AC80-3BD62EA4B75BQ34672049-90B1D077-EB73-4DD4-AA5D-622267F8167BQ34704989-F10676E6-661D-4FFF-B0C0-5EE4D8C4678CQ35024139-5FACA97C-7D70-4DC7-AC56-37F732D3DC51Q35056714-0E7AFBAA-003B-44D4-8256-25E0B8534DADQ35133520-1A4F13D9-B1F7-4926-BD1D-9D0E2EFEF588Q35510498-807AA0E9-5590-4CF5-936D-E88AE9187E9FQ36675277-34C5B8B9-6754-46DC-8CAB-BD8D9CAC9CC9Q36713767-CAFA7531-56D2-4A72-9BB3-65793D57130CQ36746307-2BED1727-E044-48EF-84CD-9B428145BA0BQ36756903-0285C700-D6B5-4604-9603-564D322D17CBQ36766772-25A470D3-EB1D-4B2B-8509-200DE443EE32Q36801738-C8A453B2-94E3-4A02-BE4C-7A10E162D4B6Q36848708-11DFEB4D-A9D0-4EF0-A9F6-5DAE9CDCDCB8Q37036734-73040870-A3C6-420D-A3AB-C5C62CE65355Q37043497-DC52E1D4-FEAF-47C2-A845-3ACE7D548944Q38060071-CBB9F28D-5A75-4A12-924A-CB1A04ABEEA4Q38809600-328623CC-1463-4AB4-B219-824166A64F0EQ38827606-32A35E19-1023-4A16-A137-F0B48D9447EEQ38907797-25FE4C0D-DD14-48E2-8B97-06F29D99D66EQ38919592-7DAA4D0E-E4FB-4344-848A-9DB85B11AC93Q38957957-A8FAF2C2-B399-4D25-96D9-45010F49C32BQ40114866-4324E673-103C-4A6E-8EA3-64B2E5B0B327Q40239055-534DABC0-5E85-4BE8-820A-CF60D3F30FE3Q40457152-A14EE14C-4925-4A20-ACDE-E6E472558496Q40613665-85DE18D6-E3BE-44B3-BA69-D26815E96577Q42584196-F5500660-82AB-4391-80CF-BDF73D4CE297Q45344075-8B43CB28-612E-44AD-92F4-24E3A92EBA6DQ48300748-7928B5A0-361C-4B24-833E-15E375E1DE77Q52429666-504B5F04-3C30-4ECF-84DB-C9D2E11C77DBQ52649693-D56D778F-72AD-42EF-9F21-3AE1D6FDBC6F
P2860
Induction of hepatocellular carcinoma by in vivo gene targeting.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Induction of hepatocellular carcinoma by in vivo gene targeting.
@ast
Induction of hepatocellular carcinoma by in vivo gene targeting.
@en
type
label
Induction of hepatocellular carcinoma by in vivo gene targeting.
@ast
Induction of hepatocellular carcinoma by in vivo gene targeting.
@en
prefLabel
Induction of hepatocellular carcinoma by in vivo gene targeting.
@ast
Induction of hepatocellular carcinoma by in vivo gene targeting.
@en
P2093
P2860
P356
P1476
Induction of hepatocellular carcinoma by in vivo gene targeting.
@en
P2093
Josep M Llovet
Pei-Rong Wang
Sara Toffanin
P2860
P304
11264-11269
P356
10.1073/PNAS.1117032109
P407
P577
2012-06-25T00:00:00Z